Acute Promyelocytic Leukaemia Cells Resistant to Retinoic Acid Show Further Perturbation of the RARα Signal Transduction System

References

• Degos L. Retinoic acid in acute promyelocytic leukaemia: A model for differentiation therapy. Curr. Opinion Oncol. 1992; 4(2)45–52
   PubMedGoogle Scholar
• Castaigne S., Chomienne C., Daniel M. T., Ballerini P., Berger R., Fenaux P., Degos L. All trans-retinoic acid as a differentiation therapy for acute promyelocytic leukaemia. I. Clinical results. Blood 1990; 76: 1704–1709
   PubMed Web of Science ®Google Scholar
• Muindi J. R. F., Frankel S. R., Miller W. M., Jakubowski A., Scheinberg D. A., Young C. W., Dimitrovsky D., Warrell R. P. Continuous treatment with all-trans-retinoic acid causes a progressive reduction in plasma drug concentrations: Implication for relapse and retinoid “resistance” in patients with acute promyelocytic leukaemia. Blood 1992; 79: 299–303
   PubMed Web of Science ®Google Scholar
• Rowley J. D., Golomb H. M., Dougherty C. 15/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia. Lancet 1977; 1: 549–550
   PubMed Web of Science ®Google Scholar
• Larsen R. A., Kondo K., Vardiman J. W., Butler A. E., Golomb H. M., Rowley J. D. Evidence for a 15; 17 translocation in every patient with acute promyelocytic leukaemia. Am. J. Med. 1984; 76: 827–841
   PubMed Web of Science ®Google Scholar
• Borrow T., Goddard A. D., Sheer D., Solomon E. Molecular analysis of APL breakpoint cluster region on chromosome 17. Science 1990; 249: 1577–1580
   PubMed Web of Science ®Google Scholar
• de The H., Chomienne C., Lanotte M., Degos L., Dejean A. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α to a novel transcribed locus. Nature 1990; 347: 558–561
   PubMed Web of Science ®Google Scholar
• Alcalay M., Zangilli D., Pandolfi P. P., Longo L., Mencarelli A., Giacomucci A., Rocchi A., Biondi A., Rambaldi A., Lococo F., Diverio D., Donti E., Grignani F., Pelicci P. G. Translocation breakpoint of acute promyelocytic leukaemia lies within retinoic acid receptor alpha locus. Proc. Natl. Acad. Sci. USA 1991; 88: 1977–1981
   PubMed Web of Science ®Google Scholar
• Alcalay M., Zangilli D., Fagioli M., Pandolfi P. P., Mencarelli A., Lococo F., Biondi A., Grignani F., Pelicci P. G. Expression pattern of the RARα-PML fusion gene in acute promyelocytic leukaemia. Proc. Natl. Acad. Sci. USA 1992; 89: 4840–4844
   PubMed Web of Science ®Google Scholar
• Chang K. S., Stass S. A., Chu D. T., Deaven L. L., Trujillo J. M., Freireich E. J. Characterization of a fusion cDNA (RARA/my1) transcribed from the t(15;17) translocation breakpoint in acute promyelocytic leukaemia. Mol. Cell. Biol. 1992; 12: 800–810
   PubMed Web of Science ®Google Scholar
• Kastner P., Perez A., Lutz Y., Rochette-Egly C., Gaub M. P., Durand B., Lanotte M., Berger R., Chambon P. Structure, localization and transcriptional properties of two classes of retinoic acid receptor a fusion proteins in acute promyelocytic leukaemia (APL): Structural similarities with a new family of oncoproteins. EMBO J. 1992; 11: 629–642
   PubMed Web of Science ®Google Scholar
• Pandolfi P. P., Alcalay M., Fagioli M., Zangilli D., Mencarelli A., Diverio D., Biondi A., Lococo F., Rambaldi A., Grignani F., Rochette-Egly C., Gaub M. P., Chambon P., Pelicci P. G. Genomic variability and alternative splicing generate multiple PML/RARα transcripts that encode aberrant PML proteins and PML/RARα isoforms in acute promyelocytic leukaemia. EMBO J. 1992; 11: 1397–1407
   PubMed Web of Science ®Google Scholar
• Kakizuka A., Miller W. H., Umesono K., Warrel R. P., Frankel S. R., Murty V. S., Dmitrovsky E., Evans R. M. Chromosomal translocation t(15;17) in human acute promyelocytic leukaemia fuses RARα with a novel putative transcription factor, PML. Cell 1991; 66: 663–674
   PubMed Web of Science ®Google Scholar
• Grignani F., Ferrucci P. F., Testa U., Talamo G., Fagioli M., Alcalay M., Mencarelli A., Grignani F., Peschle C., Nicoletti I., Pelicci P. G. The acute promyelocytic leukaemia specific PML/RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 1993; 74: 423–431
   PubMed Web of Science ®Google Scholar
• Lefebvre Ph., Thomas G., Gourmel B., Agadir A., Castaigne S., Dreux C., Degos L., Chomienne C. Pharmacokinetics of oral all-trans retinoic acid in patients with acute promyelocytic leukaemia. Leukemia 1991; 5: 1054–1058
   PubMed Web of Science ®Google Scholar
• Muindi J. R. F., Frankel S. R., Huselton C., DeGrazia F., Garland W. A., Young C. W., Warrell R. P. Clinical pharmacology of oral all-trans retinoic acid in patient with acute promyelocytic leukaemia. Cancer Res. 1992; 52: 2138–2142
   PubMed Web of Science ®Google Scholar
• Lanotte M., Martin-Thouvenin V., Najman S., Balerini P., Valensi F., Berger R. NB4, maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukaemia (M3). Blood 1991; 77: 1080–1086
   PubMed Web of Science ®Google Scholar
• Dermime S., Grignani F., Clerici M., Nervi C., Sozzi G., Talamo G. P., Marchesi E., Formelli F., Parmiani G., Pelicci P. G., Gambacorti-Passerini C. Occurrence of resistance to retinoic acid in the acute promyelocytic leukaemia cell line NB4 is associated with altered expression of the pm1/RARα protein. Blood 1993; 82: 1573–1577
   PubMed Web of Science ®Google Scholar
• Collins S. G., Robertson K. M., Mueller L. Retinoid-induced granulocytic differentiation of HL60 myeloid leukaemia cells is mediated directly through the retinoic acid receptor (RAR-a). Mol. Cell. Biol. 1990; 10: 2154–2163
   PubMed Web of Science ®Google Scholar
• Pratt M. A. C., Kralova J., McBurney M. W. A dominant negative mutation of the alpha-retinoic acid receptor gene in a retinoic acid-nonresponsive embryonic carcinoma cell. Mol. Cell. Biol. 1990; 10: 6445–6453
   PubMed Web of Science ®Google Scholar
• Robertson K. A., Emami B., Collins S. J. Retinoic acid-resistant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity. Blood 1992; 80: 1885–1889
   PubMed Web of Science ®Google Scholar
• Duprez E., Ruchaud S., Houge G., Martin-Thouvenin V., Valensi F., Kastner Ph., Berger R., Lanotte M. A retinoid acid ‘resistant’ t(15;17) acute promyelocytic leukemia cell line: isolation, morphological, immunological, and molecular features. Leukemia 1992; 6: 1281–1287
   PubMed Web of Science ®Google Scholar
• Gambacorti-Passerini C., Grignani F., Arienti F., Pandolfi P. P., Pelicci P. G., Parmiani G. Human CD4 lymphocytes specifically recognized a peptide representing the fusion region of the hybrid protein pm1/RARα present in acute promyelocytic leukaemia cells. Blood 1993; 81: 1369–1375
   PubMed Web of Science ®Google Scholar
• Taswell C., MacDonald H. R., Cerottini J. C. Clonal analysis of cytolytic T lymphocyte specificity. I. Phenotypically distinct sets of clones. J. Exp. Med. 1980; 151: 1372–1385
   PubMed Web of Science ®Google Scholar
• Gambacorti-Passerini C., Rivoltini L., Supino R., Mariani M., Parmiani G. Differential lysis of melanoma clones by autologous recombinant interleukin 2-activated lymphocytes. Relationship with spontaneous resistance to doxorubicin. Int. J. Cancer 1988; 42: 544–548
   PubMed Web of Science ®Google Scholar
• Maniatis T., Fritsch E. F., Sambrook J. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory. 1982
   Google Scholar
• Gaub M. P., Lutz Y., Ruberte E., Petkovich M., Brand N., Chambon P. Antibodies specific to the retinoic acid human nuclear receptors a B. Proc. Natl. Acad. Sci. USA 1989; 86: 3089–3093
   PubMed Web of Science ®Google Scholar
• Kelly M. A., Sidell N., Haussler M. R. Saturation analysis of cellular retinoid binding proteins: Application to retinoic acid resistant human neuroblastoma cells and to human tumors. Biochem. Cell Biol. 1987; 65: 163–172
   PubMed Web of Science ®Google Scholar
• Boylan F., Gudas L. J. Overexpression of the cellular retinoic acid binding protein-I (CRABP-I) results in a reduction in differentiation-specific gene expression in F9 teratocarcinoma cells. J. Cell Biol. 1991; 112: 965–979
   PubMed Web of Science ®Google Scholar
• Comic M., Delva L., Guidez F., Balitrand N., Degos L., Chomienne C. Induction of retinoic acid-binding protein in normal and malignant human myeloid cells by retinoic acid in acute promyelocytic leukaemia patients. Cancer Res. 1992; 52: 3329–3334
   PubMed Web of Science ®Google Scholar